Brief: Mithra Pharmaceuticals H1 Sales Up At Eur 7 Mln

Mithra Pharmaceuticals SA

26/09/2023 06:07

Sept 26 (Reuters) - Mithra Pharmaceuticals SA
 MITRA.BR :
    * MITHRA FINANCIAL RESULTS FOR FIRST-HALF 2023
    * H1 REVENUES EUR 7.0 MILLION, DRIVEN BY ESTELLE^® AND
MYRING^®
SALES
    * CASH POSITION EUR 23.7 MILLION AT END JUNE 2023
    * OUTLOOK: UPDATING FULL-YEAR ESTELLE® REVENUE GUIDANCE TO
EUR 8.5
MILLION (FROM EUR 12 MILLION) TO  REFLECT INVENTORY AND
PROMOTIONAL PRICING EFFECTS IN H1 BY MARKETING PARTNERS.

Source text for Eikon:  ID:nGNE8vPjNl 
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))